1. Dubost M, Ganter P, Maral R, et al.: Rubidomycin: A new antibiotic with cytostatic properties. Cancer Chemother Rep 41: 35–36, 1964
2. Lefrak EA, Pitha J, Rosenheim S, Gottleib JA: A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 32: 302–314, 1973
3. Singal PK, Siveski-Iliskovic N, Li T, Seneviratne C: Cardiomyopathie due á l’adriamycine et sa prévention. L’information Cardiologique 19: 289–302, 1995
4. Berlin V, Haseltine WA: Reduction of adriamycin to a semiquinone-free radical by NADPH cytochrome P-450 reductase produces DNA cleavage in a reaction mediated by molecular oxygen. J Biol Chem 256:4747–4756, 1981
5. Panneerselvam M, Bredehorst R, Vogel CW: Cell surface cytotoxic effect of immobilized doxorubicin is target cell-dependent and involves oxygen radical formation. Proc Am Assoc Cancer Res 28: 267, 1987